With the FDA’s Dec. 11 decision, the U.S. became the sixth country to clear the vaccine, which Pfizer’s late-stage clinical trial data showed to be 95 percent effective in preventing COVID-19, according to The New York Times. The federal government plans to distribute 2.9 million doses of the vaccine within 24 hours of the authorization and distribute another 2.9 million doses 21 days later for patients to get their second dose, said Gen. Gustave Perna, who oversees logistics for vaccine program Operation Warp Speed, according to CNBC.
Every state and six major cities have submitted a list of locations to the federal government where the Pfizer vaccine is to ship initially. This list is mostly hospitals, according to the Times. A CDC advisory panel in early December suggested high-risk healthcare workers, along with nursing home residents and staff, be the first to receive a COVID-19 vaccine.
Pfizer has a deal with the federal government to supply 100 million doses of its COVID-19 vaccine by March. The shots will be free to the public, according to the Times.
More articles on COVID-19 vaccines:
AstraZeneca, Russia to launch joint trial of COVID-19 vaccines before end of year
Sanofi, GSK delay COVID-19 vaccine development
J&J cuts COVID-19 vaccine trial size due to spike in cases
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
